[新辅助免疫疗法开启了胃癌治疗的新时代]
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, China.
概括
新辅助免疫疗法与化疗和向治疗相结合,对胃癌有望,改善治疗反应和生存率. 本综述探讨了其机制,集成,安全和个性化方法,以确定未来的方向.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 最近瘤免疫学的进展使免疫疗法成为胃癌的新辅助治疗策略.
- 临床试验表明,将免疫疗法与化疗和向治疗结合起来,可以提高治疗效率,并延长胃癌患者的存活时间.
研究的目的:
- 审查免疫疗法在胃癌新辅助治疗中的应用.
- 探索免疫治疗的机制,与传统疗法的整合,安全性概况,以及在胃癌中个性化精准医学的潜力.
主要方法:
- 临床试验和免疫疗法在新辅助性胃癌治疗中的研究文献综述.
- 对作用机制,组合策略,安全数据和个性化治疗方法的分析.
主要成果:
- 结合疗法包括免疫疗法,化疗和向疗法,可以改善治疗反应率.
- 有证据表明,使用基于新辅助免疫治疗的疗法,患者的生存时间延长了.
- 免疫疗法为胃癌的个性化治疗策略提供了一个有希望的途径.
结论:
- 免疫疗法代表了新辅助性胃癌治疗的重大进展.
- 与化疗和向治疗的整合优化了结果.
- 对机制和个性化方法的进一步研究对于推进胃癌护理至关重要.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.1K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
相关概念视频
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158
